In conclusion, this study suggests that the majority of subjects with low fasting IGFBP-1 and adiponectin levels benefit from bariatric surgery with improved insulin sensitivity and glucose tolerance as well as reduced risk factors for cardiovascular disease and future abnormal glucose tolerance. Here, INS is linked to abnormal glucose tolerance.